DT

Dorian Therapeutics

Acquired
Business Model
B2B
Last Round
GrantJan 2018
Rounds
2

About

Biotechnology company.

Summary

Dorian Therapeutics is a Biotech company. Its most recent funding was a Grant round in Jan 2018. Investors include Y Combinator, Pacific 8 Ventures and Blumberg Capital.

Sign up to view funding chart

Create a free account to see funding visualizations and detailed round data.

Funding History

AcquisitionMay 2025

Sign up to see all 3 rounds

Full funding history, per-round amounts, and investor participation.

Investors

Similar Companies